Wenyong Long Selected Research

Wenyong Long Research Topics

Disease

16	Neoplasms (Cancer) 01/2023 - 01/2017
12	Glioma (Gliomas) 01/2023 - 01/2017
7	Glioblastoma (Glioblastoma Multiforme) 11/2022 - 11/2019
2	Carcinogenesis 01/2023 - 11/2019
2	Meningioma (Meningiomas) 01/2023 - 07/2021
1	Hypoxia (Hypoxemia) 11/2020
1	Hematoma 10/2020
1	Lymphoma (Lymphomas) 11/2019
1	Medulloblastoma 11/2019
1	Circulating Neoplastic Cells 11/2019
1	Teratoma (Teratoid Tumor) 11/2019
1	Germinoma 11/2019
1	Brain Abscess (Abscess, Brain) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Infections 01/2018
1	Abscess 01/2018
1	Prolactinoma (Prolactinomas) 01/2018
1	Meningitis 01/2018
1	Diffuse Intrinsic Pontine Glioma 01/2017

Drug/Important Bio-Agent (IBA)

4	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 10/2020
4	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2019
2	Protein Isoforms (Isoforms)IBA 01/2023 - 11/2019
2	Long Noncoding RNAIBA 08/2021 - 10/2020
2	Proteins (Proteins, Gene)FDA Link 08/2021 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2021 - 11/2019
1	benzyloxycarbonyl- leucyl- leucyl- norleucinalIBA 01/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	Aurora KinasesIBA 11/2022
1	mRNA VaccinesIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	Autophagy-Related ProteinsIBA 08/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2021
1	Hormones (Hormone)IBA 07/2021
1	NucleotidesIBA 01/2021
1	Circular RNAIBA 01/2021
1	Mifepristone (RU 486)FDA Link 01/2021
1	Competitive Endogenous RNAIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	harman (harmane)IBA 01/2021
1	tanespimycin (17AAG)IBA 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 11/2020
1	multidrug resistance-associated protein 1IBA 10/2020
1	Circulating Tumor DNAIBA 11/2019
1	MethyltransferasesIBA 11/2019
1	N-methyladenosineIBA 11/2019
1	6-methyladenineIBA 11/2019
1	RNA Splicing FactorsIBA 11/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2019
1	Phospholipases A2 (Phospholipase A2)IBA 01/2019
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 01/2018
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2018
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018
1	TensinsIBA 01/2018
1	Tigecycline (Tygacil)FDA Link 01/2018
1	Colistin (Coly-Mycin)FDA Link 01/2018
1	amsonic acid (DAS)IBA 01/2018
1	dipinacoline glutamateIBA 01/2017

Therapy/Procedure

11	Therapeutics 01/2023 - 01/2017
3	Immunotherapy 01/2023 - 07/2021
2	Radiotherapy 01/2023 - 01/2020
2	Drug Therapy (Chemotherapy) 07/2021 - 11/2020
1	Tracheotomy 10/2020
1	Transplantation 10/2020